Effect of Guanidine Derivatives of Quinazoline on Na+/H+-Exchanger and Intraocular Pressure

Capa

Citar

Texto integral

Acesso aberto Acesso aberto
Acesso é fechado Acesso está concedido
Acesso é fechado Somente assinantes

Resumo

Based on the data of the role of Na+/H+-exchanger (NHE) in the modulation of intraocular pressure, which is the main factor in the development of glaucoma, and previously conducted studies by various authors proving the presence of inhibitory NHE-1 activity in quinazoline derivatives, nine new compounds belonging to this class were synthesized. The effect of the obtained quinazoline derivatives on the inhibition of Na+/H+-exchanger and their on intraocular pressure (IOP) in comparison with zoniporide (NHE inhibitor) and timolol (a drug for lowering IOP used in clinical practice) was studied. Among the compounds studied in vitro, all quinazoline derivatives at a concentration of 1 nM inhibited the activity of NHE-1, the most active compound was a derivative of quinazoline acetylguanidine. However, not all compounds showed IOP-reducing activity in vivo in rats. So the most active of the quinazoline derivatives are 4-oxoquinazoline acetylguanidine, its brominated derivative at position C6 and quinazoline propionylguanidine. The structure–activity analysis showed that the presence of the Br atom at the C6 position of the 4-oxoquinazoline acetylguanidine derivative leads to a maximum decrease in IOP during instillation of the solution of the compound.

Sobre autores

A. Taran

Volgograd State Medical University, Ministry of Healthcare of the Russian Federation; Volgograd Medical Scientific Center

Autor responsável pela correspondência
Email: taran-a.s@yandex.ru
Russia, 400131, Volgograd, pl. Pavshikh Bortsov 1; Russia, 400131, Volgograd, pl. Pavshikh Bortsov 1

L. Naumenko

Volgograd State Medical University, Ministry of Healthcare of the Russian Federation

Email: taran-a.s@yandex.ru
Russia, 400131, Volgograd, pl. Pavshikh Bortsov 1

Ju. Govorova

Volgograd State Medical University, Ministry of Healthcare of the Russian Federation

Email: taran-a.s@yandex.ru
Russia, 400131, Volgograd, pl. Pavshikh Bortsov 1

N. Gurova

Volgograd State Medical University, Ministry of Healthcare of the Russian Federation

Email: taran-a.s@yandex.ru
Russia, 400131, Volgograd, pl. Pavshikh Bortsov 1

A. Spasov

Volgograd State Medical University, Ministry of Healthcare of the Russian Federation; Volgograd Medical Scientific Center

Email: taran-a.s@yandex.ru
Russia, 400131, Volgograd, pl. Pavshikh Bortsov 1; Russia, 400131, Volgograd, pl. Pavshikh Bortsov 1

A. Ozerov

Volgograd State Medical University, Ministry of Healthcare of the Russian Federation; Volgograd Medical Scientific Center

Email: taran-a.s@yandex.ru
Russia, 400131, Volgograd, pl. Pavshikh Bortsov 1; Russia, 400131, Volgograd, pl. Pavshikh Bortsov 1

D. Merezhkina

Volgograd State Medical University, Ministry of Healthcare of the Russian Federation

Email: taran-a.s@yandex.ru
Russia, 400131, Volgograd, pl. Pavshikh Bortsov 1

Bibliografia

  1. Балалин С.В., Фокин В.П. // Клиническая офтальмология. 2019. Т. 19. С. 43–48. https://doi.org/10.21689/2311-7729-2019-19-1-43-48
  2. Avila M.Y., Seidler R.W., Stone R.A., Civan M.M. // Invest. Ophthalmol. Vis. Sci. 2002. V. 43. P. 1897–1902.
  3. Mandal A., Shahidullah M., Delamere N.A., Terán M.A. // Am. J. Physiol. Cell Physiol. 2009. V. 297. P. C111–C120. https://doi.org/10.1152/ajpcell.00539.2008
  4. Lupachyk S., Stavniichuk R., Komissarenko J., Drel V., Obrosov A., El-Remessy B., Pacher P., Obrosova I. // Int. J. Mol. Med. 2012. V. 29. P. 989–998. https://doi.org/10.3892/ijmm.2012.933
  5. Fidzinski P., Salvador-Silva M., Choritz L., Geibel J., Coca-Prados M. // Am. J. Physiol. Cell Physiol. 2004. V. 287. P. C655–C663. https://doi.org/10.1152/ajpcell.00552.2003
  6. Spasov A., Ozerov A., Vassiliev P., Kosolapov V., Gurova N., Kucheryavenko A., Naumenko L., Babkov D., Sirotenko V., Taran A., Litvinov R., Borisov A., Klochkov V., Merezhkina D., Miroshnikov M., Uskov G., Ovsyankina N. // Sci. Rep. 2021. V. 11. P. 1–13. https://doi.org/10.1038/s41598-021-03722-w
  7. Спасов А.А., Гурова Н.А., Тимофеева А.С., Сорокин С.М. // Эксперим. и клинич. фармакология. 2014. Т. 77. № 6. С. 13–17.
  8. Pedersen S.F., Counillon L. // Physiol. Rev. 2019. V. 99. P. 2015–2113. https://doi.org/10.1152/physrev.00028.2018
  9. Gubin D., Neroev V., Malishevskaya T., Cornelissen G., Astakhov S., Kolomeichuk S., Yuzhakova N., Kabitskaya Y., Weinert D. // J. Pineal Res. 2021. V. 70. P. e12730. https://doi.org/10.1111/jpi.12730
  10. Озеров А.А., Новиков М.С., Глухова Е.Г. // Усп. соврем. естествознания. 2016. № 2. С. 53–56.
  11. Гурова Н.А., Спасов А.А., Питерсен А.С. // Вестник Волгоград. гос. мед. ун-та. 2011. № 2. С. 70–72.
  12. Спасов А.А., Гурова Н.А., Харитонова М.В. // Эксперим. и клинич. фармакология. 2013. Т. 76. № 1. С. 43–48.
  13. Rosskopf D., Morgenstern E., Scholz W., Osswald U., Siffert W. // J. Hypertens. 1991. V. 9. № 3. P. 231–238.
  14. Kusumoto K., Igata H., Abe A., Ikeda S., Tsuboi A., Imamiya E., Fukumoto S., Shiraishi M., Watanabe T. // Br. J. Pharmacol. 2002. V. 135. P. 1995–2003. https://doi.org/10.1038/sj.bjp.0704647
  15. Солодунова Е.А., Новиков М.С., Озеров А.А. // Волгоград. научно-мед. журн. 2015. № 3. С. 36–38.
  16. Солодунова Г.Н., Волкова А.О., Коршенинникова А.С., Кучеренко А.Р., Скороход Е.Д., Толкачева В.И., Турченкова К.В., Турченкова Л.В. // Волгоград. научно-мед. журн. 2018. № 2. С. 20–22.
  17. Marcus A.J., Iezhitsa I., Agarwal R., Vassiliev P., Spasov A., Zhukovskaya O., Anisimova V., Ismail N.M. // Data Brief. 2018. V. 18. P. 523–554. https://doi.org/10.1016/j.dib.2018.03.019

Arquivos suplementares

Arquivos suplementares
Ação
1. JATS XML
2.

Baixar (11KB)
3.

Baixar (12KB)
4.

Baixar (13KB)
5.

Baixar (14KB)
6.

Baixar (69KB)
7.

Baixar (79KB)

Declaração de direitos autorais © А.С. Таран, Л.В. Науменко, Ю.А. Говорова, Н.А. Гурова, А.А. Спасов, А.А. Озеров, Д.В. Мережкина, 2023